Could Tricida Inc (NASDAQ:TCDA) Skyrocket? The Stock Had Too Little Sellers

September 30, 2018 - By Robert Shackelford

The stock of Tricida Inc (NASDAQ:TCDA) registered a decrease of 25.59% in short interest. TCDA’s total short interest was 439,400 shares in September as published by FINRA. Its down 25.59% from 590,500 shares, reported previously. With 90,300 shares average volume, it will take short sellers 5 days to cover their TCDA’s short positions. The short interest to Tricida Inc’s float is 2.29%.

The stock decreased 4.08% or $1.3 during the last trading session, reaching $30.55. About 128,598 shares traded. Tricida, Inc. (NASDAQ:TCDA) has 0.00% since September 30, 2017 and is . It has underperformed by 15.62% the S&P500.

Tricida, Inc., a late-stage pharmaceutical company, focuses on developing therapeutics to address renal, metabolic, and cardiovascular disease. The company has market cap of $1.29 billion. The Company’s lead product candidate, TRC101, a non-absorbed orally-administered polymer drug that is in Phase III clinical trials used to treat metabolic acidosis in patients with chronic kidney disease. It currently has negative earnings.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: